Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Pre-operative Therapy in Breast Cancer 11/18/2022 OBSERVATIONAL unchanged 1,377.85 0 Ultrasound Evaluation for Improving Patient Selection in vNOTES 11/21/2022 INTERVENTIONAL unchanged 1,374.85 0 Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa 11/22/2022 INTERVENTIONAL unchanged 1,373.85 0 Stepping Into Lifestyle Changes 11/22/2022 INTERVENTIONAL unchanged 1,373.85 0 REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss 11/22/2022 INTERVENTIONAL unchanged 1,373.85 0 The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection 11/22/2022 INTERVENTIONAL unchanged 1,373.85 0 Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts 11/23/2022 INTERVENTIONAL unchanged 1,372.85 0 Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology 11/23/2022 INTERVENTIONAL unchanged 1,372.85 0 Effectiveness and Cost-effectiveness of PelviSense, a Novel Biofeedback Device for Stress Urinary Incontinence in Women 11/28/2022 INTERVENTIONAL unchanged 1,367.85 0 A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer 11/29/2022 INTERVENTIONAL unchanged 1,366.85 0 Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH) 11/29/2022 OBSERVATIONAL unchanged 1,366.85 0 Efficacy and Safety Evaluation of Vi-sealer 11/29/2022 INTERVENTIONAL unchanged 1,366.85 0 Doravirine Dose Optimisation in Pregnancy 11/29/2022 INTERVENTIONAL unchanged 1,366.85 0 miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction 11/30/2022 OBSERVATIONAL unchanged 1,365.85 0 Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study 11/30/2022 INTERVENTIONAL unchanged 1,365.85 0 The Effect of Eyeliner on Tear Composition, Tear Secretion and Tear Film Stability. 12/01/2022 OBSERVATIONAL unchanged 1,364.85 0 Impact of Preop Video on Patient Anxiety 12/01/2022 INTERVENTIONAL unchanged 1,364.85 0 A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer 12/02/2022 INTERVENTIONAL unchanged 1,363.85 0 Plan of the Day Radiotherapy 12/02/2022 INTERVENTIONAL unchanged 1,363.85 0 A Cohort Study of Uterine Malignancies 12/02/2022 OBSERVATIONAL unchanged 1,363.85 0 Effectiveness of a Hip Abductor Training in Women With Stress Urinary Incontinence 12/02/2022 INTERVENTIONAL unchanged 1,363.85 0 A Study of SHR-A1811 Monotherapy or Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients 12/02/2022 INTERVENTIONAL unchanged 1,363.85 0 Optimized Acupuncture Treatment for Female Stress Urinary Incontinence 12/02/2022 INTERVENTIONAL unchanged 1,363.85 0 Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer 12/05/2022 INTERVENTIONAL unchanged 1,360.85 0 HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial) 12/05/2022 OBSERVATIONAL unchanged 1,360.85 0 Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients 12/05/2022 INTERVENTIONAL unchanged 1,360.85 0 Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer 12/06/2022 INTERVENTIONAL unchanged 1,359.85 0 Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea 12/07/2022 INTERVENTIONAL unchanged 1,358.85 0 Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia 12/07/2022 OBSERVATIONAL unchanged 1,358.85 0 Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER 12/07/2022 INTERVENTIONAL unchanged 1,358.85 0 Effects of Fall Prevention Program on the Number of Falls Among Elderly Following Total Knee Replacement 12/08/2022 INTERVENTIONAL unchanged 1,357.85 0 Biobank Cycle Collection 12/08/2022 OBSERVATIONAL unchanged 1,357.85 0 Mind Programme for Women With Breast Cancer 12/08/2022 INTERVENTIONAL unchanged 1,357.85 0 Quadratus Lumborum Block After Cesarean Section: Analgesic Efficacy of Different Concentrations of Local Anesthetics 12/09/2022 INTERVENTIONAL unchanged 1,356.85 0 Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS) 12/09/2022 INTERVENTIONAL unchanged 1,356.85 0 Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC 12/09/2022 INTERVENTIONAL unchanged 1,356.85 0 Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer 12/12/2022 INTERVENTIONAL unchanged 1,353.85 0 Autologous Transobturator Fascia Lata Sling in Treatment of Female Stress Urinary Incontinence 12/12/2022 INTERVENTIONAL unchanged 1,353.85 0 Uterus Transplantation to Treat Infertility 12/12/2022 INTERVENTIONAL unchanged 1,353.85 0 Long-term Outcomes of Autologous Transobturator Rectus Fascia Sling for Treatment of Female Stress Urinary Incontinence 12/12/2022 INTERVENTIONAL unchanged 1,353.85 0 Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer 12/12/2022 OBSERVATIONAL unchanged 1,353.85 0 A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk 12/13/2022 OBSERVATIONAL unchanged 1,352.85 0 Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage 12/13/2022 INTERVENTIONAL unchanged 1,352.85 0 Feasibility of Hyivy Device Post-Radiation for Pelvic Malignancies 12/13/2022 INTERVENTIONAL unchanged 1,352.85 0 Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. 12/13/2022 INTERVENTIONAL unchanged 1,352.85 0 Gender Related Coping and Survivorship for Genitourinary Cancers 12/14/2022 OBSERVATIONAL unchanged 1,351.85 0 Early Mental Response - The EMRE Study 12/14/2022 INTERVENTIONAL unchanged 1,351.85 0 Letrozole in Uterine Leiomyosarcoma 12/14/2022 INTERVENTIONAL unchanged 1,351.85 0 Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction 12/15/2022 INTERVENTIONAL unchanged 1,350.85 0 Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer 12/15/2022 INTERVENTIONAL unchanged 1,350.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology